Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9592207 Intranasal administration of ketamine to treat depression

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 15 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11980595 Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases
0
Edits on 6 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 6 Dec, 2023
Edits made to:
Article (+411 characters)
Article

Patent abstract

Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).

Edits on 30 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 30 Sep, 2023
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Carlos A. Zarate0
Dennis S. Charney0
Husseini K. Manji0
John H. Krystal0
Sanjay J. Mathew0
Edits on 26 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11707440 Esketamine for the treatment of depression
0
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=095922070
Edits on 19 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09592207 Intranasal administration of ketamine to treat depression US Patent 9592207 Intranasal administration of ketamine to treat depression

Infobox
Patent Number
095922070
Patent Number
95922070
Edits on 5 Oct, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 5 Oct, 2022
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
095922070
Date of Patent
March 14, 2017
0
Patent Application Number
143063820
Date Filed
June 17, 2014
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=095922070
Patent Primary Examiner
‌
Jennifer M Kim
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09592207
Edits on 11 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 11 Jan, 2022
Edits made to:
Infobox (+7 properties)
‌

 US Patent 09592207 Intranasal administration of ketamine to treat depression

Infobox
Is a
Patent
Patent
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09592207
Date of patent
March 14, 2017
Patent application number
14306382
Date Filed
June 17, 2014
Patent primary examiner
‌
Jennifer M Kim

Find more entities like US Patent 9592207 Intranasal administration of ketamine to treat depression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.